QLT holders re-elect directors at Dec. 15 AGM
2014-12-16 07:19 ET - News Release
Mr. Jason Aryeh reports
QLT ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
On a vote by ballot, the six incumbent directors of QLT Inc. were re-elected at the company's annual general meeting held on Dec. 15, 2014.
Detailed results of the vote for the election of directors are as tabulated.
Nominee Votes for % Votes withheld % Jason Aryeh 19,863,451 98.74 254,321 1.26 Dr. Geoffrey Cox, PhD 19,986,585 99.35 131,187 0.65 Dr. John Kozarich, PhD 19,993,991 99.38 123,781 0.62 Jeffrey Meckler 19,854,035 98.69 263,737 1.31 Dr. Stephen Sabba, MD 19,998,081 99.41 119,691 0.59 John Thomas 19,864,082 98.74 253,690 1.26
Shareholders at the meeting also approved the company's amended and restated advance notice policy.
Final voting results on all matters voted on at the meeting will be filed on SEDAR and EDGAR.
Strategic and business review update
The company also announces that, following the termination of the agreement and plan of merger with Auxilium Pharmaceuticals Inc. in October, 2014, the company continues its review of strategic and business options. The company has engaged Greenhill & Co. to act as adviser to the company in connection with developing, and advising the company with respect to, various strategic and business alternatives for the company. Strategic and business alternatives that the company may consider include, but are not limited to, asset divestiture, partnering or other collaboration agreements, merger, reverse merger, reorganization or similar transactions, potential acquisitions, or recapitalizations, in addition to continuing to operate the company in the ordinary course of business and developing its synthetic retinoid program.
We seek Safe Harbor.
© 2014 Canjex Publishing Ltd. All rights reserved.